Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

The document concludes that PCOS in adolescents is complex and requires comprehensive care to manage its symptoms and associated health risks.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Androgens can both increase and decrease hair growth in different parts of the body.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Choosing the right model order in brain connectivity analysis can affect the detection of differences between healthy individuals and those with seasonal affective disorder.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Some breast cancer chemotherapy can cause permanent hair loss.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.